Influenza A virus H5N1 structural proteins (Matrix protein 1 and Nucleoprotein) (H5N1 structural proteins)

The "Other structural proteins of inactivated H5N1 influenza virion" primarily encompass the Matrix protein 1 (M1) and the Nucleoprotein (NP) of the H5N1 avian influenza virus. While the surface glycoproteins Hemagglutinin (HA) and Neuraminidase (NA) are the dominant targets for neutralizing antibodies, M1 and NP are highly conserved internal proteins that play essential roles in the viral life cycle. M1 provides the structural scaffold beneath the viral lipid envelope and mediates the assembly and budding of new virions, while NP coats the viral RNA segments to form ribonucleoprotein complexes required for replication and transcription (CDC, 2023; NIH, 2024). In the context of inactivated H5N1 vaccines, these proteins serve as critical antigens that stimulate heterosubtypic immunity, particularly through the activation of CD8+ cytotoxic T lymphocytes and CD4+ helper T cells (PubMed: 25601461). This cellular immune response is vital for providing a broader range of protection against various H5N1 clades, as these internal proteins do not undergo the rapid antigenic drift seen in HA and NA. Consequently, their presence in whole-virus or split-virus inactivated vaccines enhances the overall efficacy and durability of the vaccine-induced protection against severe disease (FDA, 2020; WHO, 2024).

Other names

Matrix protein 1NucleoproteinM1 proteinNP proteinInternal viral proteins of H5N1Non-HA/NA structural proteins

Induction of cross-reactive cellular and humoral immunity against conserved internal viral antigens to provide protection against H5N1 infection.